DNA Capital
Venture capitalActively deployingSão Paulo · Seed–Late Stage · 16 people tracked
Find your way into DNA Capital
Sign up to see every warm intro you have to DNA Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the DNA Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
DNA Capital concentrates exclusively on the healthcare sector, investing across the full lifecycle of companies from early-growth through late-stage. The firm emphasizes long-term partnerships and flexibility to participate at any stage of a company's development. It leverages a network of specialist advisors, an operating team, and an investment team that work together to deliver expertise and comprehensive support across its verticals, aiming to contribute to each company's value-creation journey. Its portfolio is global and spans multiple development stages, with activity across venture capital and private equity including Series A, Series B, growth, and late-stage investments.
Source: firm website, verified Oct 25, 2026.
Team · 16 people
from the firm's website & public directoriesCamila Guimarães joined DNA Capital in 2019 as Chief Legal Officer, overseeing Compliance, Risk, AML, and ESG. She previously served as Legal Counsel at Farallon Capital Management's São Paulo office and worked as a lawyer at Stocche Forbes Advogados. She holds a double bachelor's degree in Business Administration and Law from Fundação Getulio Vargas (FGV).
Daniel Studart is a private equity analyst at DNA Capital, based in São Paulo. He previously worked on the private equity team at Pátria Investimentos, where he covered the food and beverage sector before moving to the M&A team of a food retail portfolio company. He holds a degree in Civil-Aeronautical Engineering from the Instituto Tecnológico de Aeronáutica (ITA).
Henrique Bandeira is an associate at DNA Capital working on venture capital investments. He previously spent over five years in M&A and strategic consulting at ADVISIA OC&C and Oliver Wyman, and worked two years at an educational NGO. He holds a bachelor's degree in Chemical Engineering from Universidade Federal do Rio Grande do Sul.
José Eduardo Guinle is a partner at DNA Capital working on venture capital investments. He previously worked in the firm's private equity practice investing in growth and later-stage companies, and began his career in EBX Holding's corporate finance and legal team. He holds an LL.B. from Pontifícia Universidade Católica do Rio de Janeiro, has finance training from COPPEAD-UFRJ, and holds the CGE certification from ANBIMA.
Julia Prado is a private equity associate at DNA Capital, based in São Paulo. She previously worked on the private equity team at Pátria Investimentos in the M&A team of Crop Care Holding, and earlier spent two years as a private equity analyst and three years as a wealth management analyst at Icatu Holding. She is a CFA Charterholder and holds a bachelor's degree in Industrial Engineering from Pontifícia Universidade Católica do Rio de Janeiro.
Lucas Cortez is a Vice President at DNA Capital working on venture capital investments. Before joining the firm, he spent five years as an analyst and associate at ADVISIA OC&C, working on projects across multiple sectors. He holds a bachelor's degree in Mechanical Engineering from Universidade Estadual de Campinas and the CGE certification from ANBIMA.
Luiz Felipe Costa is a partner at DNA Capital, focused on private equity and based in São Paulo. Before joining the firm, he was a founding partner at Stocche Forbes Advogados and a partner at Machado Meyer Advogados, with over 20 years of experience in law and cross-border M&A transactions. He holds a B.Sc. and an LLM in Law from Universidade de São Paulo.
Luiz Noronha is a partner at DNA Capital working on venture capital investments, with more than fifteen years of experience investing in early-stage companies. Before DNA Capital, he invested in technology companies at DGF Investimentos and earlier worked on the investment team of Ficus Investimentos, where he served as a board member and CFO of a portfolio company. He earned a Bachelor of Science in Mechanical Engineering from Universidade de São Paulo.
Mario Sergio Ribeiro is a partner at DNA Capital focused on private equity. Before DNA Capital, he worked in asset management at Banco Bozano, was Vice-President at One Health, and Sales Manager at Grupo Amil. He holds an Economics degree from Instituto Brasileiro de Mercado de Capitais and an MBA in Business Administration and Marketing from Fundação Instituto de Administração, with additional executive education at INSEAD and Singularity University.
Partha Mishra is a partner at DNA Capital focused on venture capital investments. He previously served for 12 years as president and CEO of Optum Global Solutions, the healthcare technology and services unit of UnitedHealth Group, and earlier held healthcare leadership roles at Cognizant and Capgemini. He holds a bachelor's degree in electrical engineering technology from VSS University of Technology and an MBA from the Xavier Institute of Management in India.
Pedro Bueno is a partner at DNA Capital and serves as CEO of the company formed by the merger of diagnostics firm DASA and hospital chain Rede Ímpar, sitting on the boards of both. He started in investment banking at BTG Pactual working on M&A transactions, then joined Amil in 2012 and took part in its sale to UnitedHealth Group before becoming CEO of DASA. He holds a B.A. in Economics from Pontifícia Universidade Católica do Rio de Janeiro.
Ricardo Lima is the CFO at DNA Capital. He previously spent five years as a controller at Viveo S.A., where he took part in more than 25 acquisitions and the company's 2021 IPO, and earlier held roles as CFO of oil and gas company Maxen, M&A manager at A Geradora, and investment professional at DGF Investimentos, Pulsar Invest, and GG Investimentos. He holds a degree in Business Administration from FGV-EAESP.
Thayan Hartmann is a partner on the private equity team at DNA Capital. Before joining the firm, he was an associate in the private equity team at Angra Partners. He is a CFA Charterholder, a Securities Portfolio Manager authorized by the CVM, and holds the CGA designation from ANBIMA, along with a degree in Aerospace Engineering from the University of São Paulo.
Founder mafia
2 people who came through DNA Capital went on to found or lead other companies.
What they invest in
from 12 of 21 portfolio companiesDigital Health ×9Healthtech ×8AI & Machine Learning ×4Enterprise Software ×3SaaS ×3HR Tech ×2Medical Devices ×2Mental Health ×2
HQs:United States×5Brazil×4Australia×1Israel×1
Investments · 21 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 12022 · 22021 · 22020 · 12019 · 312 dated
Beep is a fully digital home healthcare service that provides laboratory tests (5,000+ types), vaccines, and infusions at the patient's home, booked via its app or website.
Digital HealthHealthtech
Vander Corteze(Founder)Vander Vinícius Corteze(Founder)
Co-investorsThe Lightsmith GroupValor Capital GroupWormhole CapitalActyus
Cured builds cloud-based enterprise software for healthcare organizations to modernize operations and improve patient and employee experiences.
AI & Machine LearningCloud ComputingDigital HealthEnterprise SoftwareHealthtechMarketing TechSan Francisco, US
Rohit(Co-Founder and Chief Customer Officer)inAshmer Aslam(Executive Officer, Director)inAndrew Sawyer(Executive Officer, Director)in
Co-investorsCU Healthcare Innovation FundHeadwater VenturesHigh AlphaMatchstick VenturesWaterline Ventures
Curie.Bio is a biotech venture firm pairing seed capital with in-house drug discovery support for therapeutics founders.
Zach Weinberg(Founder)inAlexis Borisy(Founder)Christoph Lengauer(Founder)
Co-investorsAlleyCorpARCH Venture PartnersBoxGroupF-Prime CapitalGV (Google Ventures)Lightstone Ventures+5 more
Dasa operates a broad network of laboratories and healthcare professionals in Brazil, offering diagnostic and health services spanning prevention to treatment for patients, physicians, and companies.
Digital HealthHealthtechMedical Devices
Figments built narrative games, virtual influencers, AI characters, and creative tools over seven years, culminating in Plotdrive, an AI writing engine for long-form storytelling.
AI & Machine LearningCreator EconomyEnterprise SoftwareMedia & EntertainmentSaaSLos Angeles, US
Jay Rosenkrantz(Founder)inScott Rosenkrantz(Co-founder \u0026 Head of Product)in
Co-investorsTRANSCENDY CombinatorAscensive AssetsBDMII2BF Global Venturesmark vc+6 more
MeMed develops a rapid 15-minute diagnostic test using machine learning to distinguish bacterial from viral infections by analyzing immune system biomarkers.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesIsrael, IL
Eran Eden(Co-founder and CEO)in
BoardOri Hadomi(Chairman of the Board of Directors)
Co-investorsHorizons VenturesMetaplanetQualcomm VenturesUnion Tech VenturesWestern Technology InvestmentBridge One+4 more
Memed operates a digital prescription platform in Brazil that connects physicians, patients, pharmacies, pharmaceutical companies, and health institutions.
Digital HealthHealthtechSaaS
Marcel Ribeiro(Founder)inRicardo Moraes(Founder)inRené Moraes(Founder)in
Co-investorsDGFMONASHEESBridge One
Nice Healthcare provides on-demand primary care and health services that come to patients' locations, aiming to reduce costs and improve accessibility compared to traditional clinic-based care.
Digital HealthEnterprise SoftwareHealthtechRoseville, US
Thompson Aderinkomi(Co-Founder & CEO)inGenevieve Swenson(Co-Founder & COO)in
BoardAllison Santos(Co-Founder & Chief Business Officer)inRobert M. Greenglass(Director)Partha Sarathi Mishra(Director)in
Co-investorsConductive VenturesGaingelsGROOVE CAPITALHeadwater VenturesThe Gramercy FundWaterline Ventures+1 more
Reema Health provides a personalized, community-based care model that connects people to health care and social support services in their local communities.
Digital HealthHealthtechImpact & Social GoodMental HealthMinneapolis, US
Justin Ley(CEO)inMatt(Chief Product Officer)
BoardHelen Ciesielski(Director)inMatthew Swanson(Director)Ellen Herlacher(Director)inAmon Anderson(Director)
Co-investorsAcumen AmericaDigitalis VenturesGROOVE CAPITALHC9 VenturesHeadwater VenturesLRVHealth+4 more
The Mom Project operates an AI-powered marketplace that matches mothers and allies with employment opportunities at companies across various sectors, offering flexible remote, hybrid, and onsite roles.
AI & Machine LearningB2B MarketplacesFuture of WorkHR TechMarketplaces
Tricia House(President & COO)inAllison Robinson(Founder)
Co-investors7GC & CoAtlanta SeedBBG VenturesGrotech VenturesHigh AlphaIngeborg Investments+10 more
Vitable offers personalised daily vitamin and supplement subscriptions, using an online quiz developed with naturopaths, nutritionists, and pharmacists to tailor recommendations to a person's health goals, lifestyle, and diet.
ConsumerDirect to ConsumerWellness & FitnessSydney, AU
Ilyas Anane(Co-Founder)inLarah Loutati(Co-Founder & CEO)in
Co-investorsBrenteca InvestmentsCoughdrop CapitalFlying Fox VenturesRocket Internet SEScale InvestorsArtesian+5 more
Vitable provides a health benefits platform offering affordable, accessible healthcare to employers and their employees, with a focus on serving everyday workers and low-income populations.
Digital HealthHealthtechHR TechInsurTechSaaSPhiladelphia, US
Joseph Kitonga(Founder)inRon Davidson(Head of Strategy and Ops)Farabi Sameer(Product)Kyle Self(Demand Gen)Amanda Matz(Recruiting Manager)Chrisantha Pinto(Chief of Staff)
Co-investorsCherryrock CapitalCoalition OperatorsCommerce VenturesFirst Round CapitalNVP CapitalOpen Opportunity Fund+13 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
blüümFeegowFeegow ClinicNefroClínicasPiwiSanarThe CareVoiceViveo
Exits · 1
1 acquisitionsCuredacq. by Innovaccer
Portfolio news
latest coverage across their companies
The Mom Project · forgeglobal.com · Sep 12, 2026
Memed · thesaasnews.com · Jun 2, 2026
Memed · thesaasnews.com · Jun 2, 2026
Reema · biospace.com · Dec 3, 2025
Frequently asked questions
- How many investments has DNA Capital made?
- DNA Capital has 21 tracked investments, 1 of which have exited, including 4 dated in the last 24 months.
- What stage does DNA Capital invest at?
- DNA Capital invests at the Seed, Series A, Series B, Growth, Late Stage stages.
- What is DNA Capital's typical check size?
- DNA Capital typically writes checks of $100K – $5M.
- What sectors does DNA Capital focus on?
- DNA Capital focuses on Biotech, Digital Health, Healthtech.
- Where is DNA Capital located?
- DNA Capital is headquartered in São Paulo, BR.
- Does DNA Capital lead rounds?
- Yes, DNA Capital leads investment rounds.
- Who does DNA Capital co-invest with?
- DNA Capital most often shares deals with Wormhole Capital, Conductive Ventures, GV (Google Ventures), among 22 tracked co-investors.
Images
Co-investors · 6
High Alpha is a venture firm that creates and funds B2B SaaS companies, partnering with founders to build enterprise software businesses. It operates a venture capital arm (Capital) and a company-building arm (Studio).
Matchstick Ventures is an early-stage venture firm that backs ambitious founders 'between the coasts,' partnering at the pre-seed and seed stages with capital, time and resources.
HC9 Ventures is an early-stage venture capital firm investing in healthcare companies, drawing on the industry expertise of its limited partners and advisors to help build and grow its portfolio.
Valor Capital Group is a cross-border venture fund connecting the US, Latin American, and global technology markets, investing in consumer internet and enterprise software companies.
Redpoint eventures is a venture capital firm supporting technology entrepreneurs in Latin America, combining local presence with the global network and track record of a Silicon Valley VC. It offers insight, company building, financing and exit support.
Firms observed investing alongside DNA Capital, from public investor directories. Shared companies are the overlap with DNA Capital's recorded portfolio.
Similar investors
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.
Deerfield Management Company is a healthcare-focused investment firm, founded in 1994, that advances healthcare through investment, intelligence, and philanthropy.
Foresite Capital is a healthcare-focused investment firm backing companies at the intersection of technology and biotechnology to personalize healthcare and accelerate medical innovation.
Vivo Capital is an investment firm focused on the healthcare sector, having invested in over 460 healthcare companies across multiple geographies and segments of the industry value chain.























.png)

























__Twitter.png)






























